FMR LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$195,092,582
-18.9%
7,089,120
+0.0%
0.02%
-15.0%
Q2 2023$240,491,429
-52.8%
7,087,870
-50.0%
0.02%
-13.0%
Q1 2023$509,554,372
+61.8%
14,162,156
+100.5%
0.02%
-25.8%
Q4 2022$314,885,891
+59.7%
7,064,974
+0.7%
0.03%
+47.6%
Q3 2022$197,215,000
+4.3%
7,015,843
+0.0%
0.02%
+10.5%
Q2 2022$189,074,000
-20.8%
7,013,144
+0.0%
0.02%0.0%
Q1 2022$238,769,000
-11.7%
7,010,253
+0.2%
0.02%
-5.0%
Q4 2021$270,464,000
-10.8%
6,999,580
+24.7%
0.02%
-16.7%
Q3 2021$303,172,000
+2375.3%
5,615,333
+1433.0%
0.02%
+2300.0%
Q2 2021$12,248,000
+76.0%
366,295
+8.4%
0.00%0.0%
Q1 2021$6,961,000337,900
+33789900.0%
0.00%
Q4 2020$0
-100.0%
1
-98.6%
0.00%
Q3 2020$1,00073
+46.0%
0.00%
Q4 2019$050
+150.0%
0.00%
Q3 2019$0200.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 761,398$41,108,00010.12%
Opaleye Management Inc. 985,000$53,045,0009.91%
VR Adviser, LLC 1,098,174$59,290,0007.62%
ACUTA CAPITAL PARTNERS, LLC 337,500$18,222,0006.43%
TSP Capital Management Group, LLC 271,429$14,654,0005.00%
Ghost Tree Capital, LLC 255,000$13,767,0004.03%
COMMODORE CAPITAL LP 248,207$13,401,0003.53%
RTW INVESTMENTS, LP 3,908,947$211,044,0003.18%
Ikarian Capital, LLC 791,600$42,741,0003.01%
Redmile Group, LLC 3,043,298$164,308,0002.87%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders